Perigon Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,444
| Closed | -$336K | – | 512 |
|
|
2021
Q1 | $336K | Buy |
4,444
+3,695
| +493% | +$279K | 0.03% | 365 |
|
|
2020
Q4 | $66K | Buy |
+749
| New | +$66K | 0.01% | 651 |
|
|
2019
Q3 | – | Sell |
-2,709
| Closed | -$232K | – | 241 |
|
|
2019
Q2 | $232K | Hold |
2,709
| – | – | 0.05% | 212 |
|
|
2019
Q1 | $231K | Hold |
2,709
| – | – | 0.05% | 196 |
|
|
2018
Q4 | $259K | Hold |
2,709
| – | – | 0.07% | 175 |
|
|
2018
Q3 | $263K | Sell |
2,709
-452
| -14% | -$43.9K | 0.06% | 191 |
|
|
2018
Q2 | $298K | Buy |
+3,161
| New | +$298K | 0.09% | 183 |
|
|
2017
Q4 | – | Sell |
-2,169
| Closed | -$202K | – | 610 |
|
|
2017
Q3 | $202K | Sell |
2,169
-4,137
| -66% | -$385K | 0.07% | 198 |
|
|
2017
Q2 | $573K | Buy |
6,306
+330
| +6% | +$30K | 0.12% | 160 |
|
|
2017
Q1 | $525K | Buy |
5,976
+811
| +16% | +$71.2K | 0.11% | 173 |
|
|
2016
Q4 | $485K | Buy |
5,165
+506
| +11% | +$47.5K | 0.11% | 179 |
|
|
2016
Q3 | $431K | Buy |
4,659
+536
| +13% | +$49.6K | 0.11% | 156 |
|
|
2016
Q2 | $321K | Buy |
+4,123
| New | +$321K | 0.09% | 167 |
|